An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.
about
H5N1 vaccines in humansA Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsDevelopment of live attenuated influenza vaccines against pandemic influenza strains.A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.Potency of an inactivated influenza vaccine prepared from A/duck/Hong Kong/960/1980 (H6N2) against a challenge with A/duck/Vietnam/OIE-0033/2012 (H6N2) in mice.The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccinesSafety, immunogenicity and infectivity of new live attenuated influenza vaccines.Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9).The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets.Animal models for influenza viruses: implications for universal vaccine developmentSafety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 studyExperimental infection of adults with recombinant wild-type human metapneumovirus.The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza.Intranasal live influenza vaccine priming elicits localized B cell responses in mediastinal lymph nodes.
P2860
Q27000896-69694DA8-9C40-4B1F-9836-F6E4923A48C0Q30204020-D0481FB5-6483-4420-9B4C-78B309959C2EQ30209998-788BE1B3-A021-4ABA-AA22-0BDDD06509B7Q30359896-27FDC083-DE09-46F3-A4C4-263817A76C32Q30362332-2E93CF39-B6EE-4A19-B665-710CCB00A1C6Q30362515-E4087B7D-F48E-45C9-B2F7-25BAD2C4A219Q30365696-D9CFFD72-DD85-4DEC-8E98-504D369F8B3AQ30378132-440814CC-0A24-4818-825C-72D1448FE199Q30382351-1F50ED7A-5813-41C4-8230-00A9356FD7BBQ30410954-E7D6B04F-A572-4ECF-B685-A0B38FD4A5CFQ30517014-99F8F119-D91B-41BD-BFD2-ED51E519E337Q33931916-49B12A8E-891C-4B2A-8CCC-CF6AD20581B3Q34809686-38E62D44-067B-4F6B-9E26-72D5AA933869Q36621905-A7EADE47-9A69-4FC5-A199-8313EE4C43EAQ37247449-3EAE074C-1CE8-4151-8EEB-A195646B1520Q38001862-12D47BDB-F54E-4948-9254-6D64BA6F8745Q50146914-634B9BD7-B96B-447E-87C6-5E995BE4A42F
P2860
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
An open label Phase I trial of ...... rus vaccine in healthy adults.
@ast
An open label Phase I trial of ...... rus vaccine in healthy adults.
@en
type
label
An open label Phase I trial of ...... rus vaccine in healthy adults.
@ast
An open label Phase I trial of ...... rus vaccine in healthy adults.
@en
prefLabel
An open label Phase I trial of ...... rus vaccine in healthy adults.
@ast
An open label Phase I trial of ...... rus vaccine in healthy adults.
@en
P2093
P2860
P50
P1433
P1476
An open label Phase I trial of ...... rus vaccine in healthy adults.
@en
P2093
Bhagvanji Thumar
Bridget A McMahon
Catherine J Luke
Elaine W Lamirande
Grace L Chen
Kathy L Coelingh
Kawsar R Talaat
P2860
P304
P356
10.1016/J.VACCINE.2011.02.043
P407
P577
2011-03-04T00:00:00Z